OptimizeRx Corporation (OPRX)

Market Cap	339.00M
Revenue (ttm)	104.75M
Net Income (ttm)	-9.87M
Shares Out	18.57M
EPS (ttm)	-0.54
PE Ratio	n/a
Forward PE	34.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	281,214
Open	18.11
Previous Close	18.41
Day's Range	17.27 - 18.53
52-Week Range	3.78 - 19.47
Beta	1.20
Analysts	Buy
Price Target	11.81 (-35.32%)
Earnings Date	Nov 12, 2025

About OPRX

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2006
• Employees: 129
• Stock Exchange: NASDAQ
• Ticker Symbol: OPRX
• Website: https://www.optimizerx.com

Financial Performance

In 2024, OptimizeRx's revenue was $92.13 million, an increase of 28.81% compared to the previous year's $71.52 million. Losses were -$20.11 million, 14.5% more than in 2023.

Analyst Summary

According to 8 analysts, the average rating for OPRX stock is "Buy." The 12-month stock price target is $11.81, which is a decrease of -35.32% from the latest price.

Price Target

$11.81

(-35.32% downside)

Analyst Consensus: Buy